An underground market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, based on recent findings.
Investigational Drug Gaining Traction Online
The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed fat-burning properties. Viewers are urged to contact these accounts directly for supplier links, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with thousands of members share comparison photos, injection guides and assertions of next-day British shipping. Vendors market the substance there before directing buyers to other platforms for purchases.
Understanding Retatrutide
This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Experts Voice Concerns
However, doctors and chemists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in users injecting products of uncertain source.
Some experts stated the demand for retatrutide could be linked to the rising cost of licensed slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the British medical regulations.
Several influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach pharmaceutical, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment.
Service Response and Content Removal
Based on TikTok, the service has removed violative material and prohibited associated keywords and search suggestions. The organization stated it was committed to maintaining the service safe and investing in strengthening enforcement strategies.
Online Marketplace Operations
Investigations also discovered groups with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, filled with photos of slimming results, glowing testimonials and detailed guides for preparing or administering at home.
After moments of joining one group, a seller shared WhatsApp details, where most purchases take place. The seller provided an guidebook and promised shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.
Product Information and Pricing
Within these groups, posts show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When asked how much time a pen should be used, vendors give contradictory answers varying between a several days to “depends on your body”.
Platform Oversight and Security Measures
A spokesperson for the messaging service stated it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering materials they cannot confirm. Even if the science behind this drug is sound, these digital products may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.
Her staff has previously seen individuals harmed by personal administration from unverified suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”
Producer Position
A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject users to potentially significant health risks”.
